Log in

NASDAQ:PTE - Polarityte Stock Price, Forecast & News

-0.06 (-3.64 %)
(As of 02/23/2020 05:43 AM ET)
Today's Range
Now: $1.59
50-Day Range
MA: $2.96
52-Week Range
Now: $1.59
Volume343,604 shs
Average Volume795,699 shs
Market Capitalization$43.31 million
P/E RatioN/A
Dividend YieldN/A
PolarityTE, Inc., a biotechnology and regenerative biomaterials company, focuses on discovering, designing, and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine and Contract Services. It offers SkinTE, a tissue product for treatment of defects of the skin, as well as contract research services. The company also develops OsteoTE, an autologous homologous bone regeneration product; and CartTE, an autologous cartilage regeneration product. In addition, it develops AdipoTE to optimize the delivery of autologous fat; AngioTE for vascular regeneration; NeuralTE for peripheral nerve injuries of the extremities, as well as for patients with neuromas or chronic compression due to joint replacements, migraines, craniofacial injuries, carpal tunnel syndrome, and those who have undergone hernia or abdominal-based procedures; UroTE for the delivery of autologous urogenital epithelium and submucosa; LiverTE to address various causes of liver failure; and BowelTE to deliver an optimized autologous construct to aid in the regeneration of bowel tissue. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Current SymbolNASDAQ:PTE



Sales & Book Value

Annual Sales$1.56 million
Book Value$3.36 per share



Market Cap$43.31 million
Next Earnings DateN/A

Receive PTE News and Ratings via Email

Sign-up to receive the latest news and ratings for PTE and its competitors with MarketBeat's FREE daily newsletter.

Polarityte (NASDAQ:PTE) Frequently Asked Questions

What is Polarityte's stock symbol?

Polarityte trades on the NASDAQ under the ticker symbol "PTE."

How were Polarityte's earnings last quarter?

Polarityte Inc (NASDAQ:PTE) released its quarterly earnings results on Tuesday, November, 12th. The company reported ($0.87) earnings per share for the quarter, topping analysts' consensus estimates of ($1.01) by $0.14. The firm had revenue of $1.40 million for the quarter, compared to analyst estimates of $1.41 million. During the same period last year, the company earned ($0.86) EPS. View Polarityte's Earnings History.

What price target have analysts set for PTE?

7 brokers have issued twelve-month price targets for Polarityte's shares. Their forecasts range from $3.00 to $26.00. On average, they anticipate Polarityte's stock price to reach $12.86 in the next twelve months. This suggests a possible upside of 708.6% from the stock's current price. View Analyst Price Targets for Polarityte.

What is the consensus analysts' recommendation for Polarityte?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Polarityte in the last year. There are currently 1 sell rating and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Polarityte.

Has Polarityte been receiving favorable news coverage?

Headlines about PTE stock have trended very negative recently, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Polarityte earned a coverage optimism score of -3.4 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Polarityte.

Who are some of Polarityte's key competitors?

What other stocks do shareholders of Polarityte own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Polarityte investors own include Aduro BioTech (ADRO), Agile Therapeutics (AGRX), Wirecard (WDI), Crispr Therapeutics (CRSP), FibroGen (FGEN), Nabriva Therapeutics (NBRV), VBI Vaccines (VBIV), Vaxart (VXRT), Canopy Growth (CGC) and Armata Pharmaceuticals (ARMP).

Who are Polarityte's key executives?

Polarityte's management team includes the folowing people:
  • Dr. Denver M. Lough, Chairman, CEO and Chief R&D Officer (Age 38)
  • Mr. Paul Elliot Mann, Chief Financial Officer
  • Mr. Richard Hague, Chief Operating Officer (Age 59)
  • Dr. David Blum, Chief Design & Technology Officer
  • Mr. Nikolai Sopko, Chief Scientific Officer and VP of R&D

Who are Polarityte's major shareholders?

Polarityte's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Geode Capital Management LLC (0.88%), Levin Capital Strategies L.P. (0.35%), Renaissance Technologies LLC (0.27%), Private Advisor Group LLC (0.23%), Comprehensive Portfolio Management LLC (0.22%) and Cambridge Investment Research Advisors Inc. (0.20%). Company insiders that own Polarityte stock include Cameron J Hoyler, David B Seaburg, Denver Lough, Edward Winslow Swanson, Paul Elliot Mann, Peter A Cohen, Rainer M Erdtmann, Richard Hague and Steve Gorlin. View Institutional Ownership Trends for Polarityte.

Which institutional investors are selling Polarityte stock?

PTE stock was sold by a variety of institutional investors in the last quarter, including Janney Montgomery Scott LLC, Geode Capital Management LLC and Oppenheimer & Co. Inc.. Company insiders that have sold Polarityte company stock in the last year include Cameron J Hoyler, David B Seaburg, Denver Lough, Paul Elliot Mann, Rainer M Erdtmann, Richard Hague and Steve Gorlin. View Insider Buying and Selling for Polarityte.

Which institutional investors are buying Polarityte stock?

PTE stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Levin Capital Strategies L.P., Private Advisor Group LLC, Capital Wealth Alliance LLC, Comprehensive Portfolio Management LLC, Bernardo Wealth Planning LLC, UBS Group AG and Cambridge Investment Research Advisors Inc.. Company insiders that have bought Polarityte stock in the last two years include Edward Winslow Swanson, Paul Elliot Mann, Peter A Cohen and Rainer M Erdtmann. View Insider Buying and Selling for Polarityte.

How do I buy shares of Polarityte?

Shares of PTE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Polarityte's stock price today?

One share of PTE stock can currently be purchased for approximately $1.59.

How big of a company is Polarityte?

Polarityte has a market capitalization of $43.31 million and generates $1.56 million in revenue each year. Polarityte employs 123 workers across the globe.View Additional Information About Polarityte.

What is Polarityte's official website?

The official website for Polarityte is http://www.polarityte.com/.

How can I contact Polarityte?

Polarityte's mailing address is 123 NORTH WRIGHT BROTHERS DRIVE, SALT LAKE CITY UT, 84116. The company can be reached via phone at 385-237-2279 or via email at [email protected]

MarketBeat Community Rating for Polarityte (NASDAQ PTE)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  97 (Vote Outperform)
Underperform Votes:  87 (Vote Underperform)
Total Votes:  184
MarketBeat's community ratings are surveys of what our community members think about Polarityte and other stocks. Vote "Outperform" if you believe PTE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PTE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel